Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5
- Intermediate Risk6–9
- High Risk10–23
The Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include sex. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
The CARG-TT estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients (age >65). It uses 11 geriatric assessment variables, laboratory values, and patient characteristics to predict chemotherapy toxicity risk.
Clinical Indication
The Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT) is indicated for bedside clinical practice to support The CARG-TT estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients (age >65). It uses 11 geriatric assessment variables, laboratory values, and patient characteristics to predict chemotherapy toxicity risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Recommended by ASCO guidelines for geriatric oncology assessment.
Score = (2 × age_72_or_older) + (2 × gi_gu_cancer) + (2 × standard_dose_chemo) + (2 × polychemotherapy) + (3 × hemoglobin_low) + (3 × creatinine_clearance_low) + (2 × hearing_impaired) + (3 × falls_past_6_months) + (1 × medication_assistance) + (2 × walking_limited) + (1 × social_activity_decreased)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Patient sex (used for hemoglobin thresholds) |
| age_72_or_older | string | Yes | Patient age 72 years or older |
| gi_gu_cancer | string | Yes | Gastrointestinal or genitourinary cancer type |
| standard_dose_chemo | string | Yes | Standard-dose chemotherapy (vs. reduced dose) |
| polychemotherapy | string | Yes | Polychemotherapy (more than one chemotherapy drug) |
| hemoglobin_low | string | Yes | Low hemoglobin (males <11 g/dL, females <10 g/dL) |
| creatinine_clearance_low | string | Yes | Creatinine clearance <34 mL/min |
| hearing_impaired | string | Yes | Hearing fair, poor, or totally deaf (vs. excellent/good) |
| falls_past_6_months | string | Yes | History of falls in the preceding 6 months |
| medication_assistance | string | Yes | Needs assistance with medication use |
| walking_limited | string | Yes | Limited in walking one block or more |
| social_activity_decreased | string | Yes | Decreased social activity because of health |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Low Risk | 30% risk of grade ≥3 toxicity |
| 6–9 | Intermediate Risk | 52% risk of grade ≥3 toxicity |
| 10–23 | High Risk | 83% risk of grade ≥3 toxicity |
Evidence-Based References (EBM)
- Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011 Sep 1;29(25):3457-65. doi: 10.1200/JCO.2011.34.7625.DOI: 10.1200/JCO.2011.34.7625
- Magnuson A, Sattar S, Nightingale G, Saracino R, Skoneczka J, Trevino KM, et al. A practical guide to geriatric syndromes in older adults with cancer: A focus on falls, cognition, polypharmacy, and depression. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e96-e109. doi: 10.1200/EDBK_237641.DOI: 10.1200/EDBK_237641
- Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul 1;118(13):3377-86. doi: 10.1002/cncr.26646.DOI: 10.1002/cncr.26646